Hotline:4006-508-908

Services
Effect of Targeted Drugs
Drug Type Items to be Tested
Gefitinib
Erlotinib
Icotinib
 EGFR mutation
 KRAS mutation

.PIK3CA mutation
.BIM polymorphism
Crizotinib .EML4-ALK merging
.ROS1 merging
Bevacizumab
Sunitinib
Sorafenib
Ramucirumab
.VEGF expression
.VEGFR2 expression

.VEGFR1 expression
Cetuximab
Panitumumab
Nimotuzumab
.KRAS mutation
.BRAF mutation

.NRAS mutation
.PIK3CA mutation
.EGFR expression
Trastuzumab
Lapatinib
.HER2 proliferation            
.PIK3CA mutation
Imatinib .CKIT mutation
.PDGFRA mutation
 
Vemurrafenib .BRAF mutation
Sorafenib
Sunitinib
Vandetanib
.KIF5B-RET merging

©Beijing ACCB Biotech Company Limited     All Rights Reserved Jing ICP Registration No05018742-1     Site map     

ӣ博乐彩票官网  迅雷彩票注册  98彩票官网  顺发彩票注册  快赢彩票官网  

: վϼͼƬԴ,еκϢͷΡƷȨԭУ뱾վ޹أûַȨ棬ϵǸ֪ǽɾ